Who we are Our team Investigators Investigators Dr Maan Alwan MBChB FRACP FRCPAHaematologist / Clinical Lead Dr Maan Alwan is a dual qualified clinical and laboratory haematologist. He completed his specialist training at Royal North Shore Hospital in Sydney. Dr Alwan has clinical interest in both malignant and non-malignant haematology. He is also strongly involved in clinical trials and research in myeloma, lymphoma, thrombosis and haemostasis as a clinical investigator at Perth Blood Institute. Dr Alwan’s private consulting rooms are based at Western Haematology & Oncology Clinics in West Perth, and he also provides consulting and clinical services at Hollywood Private Hospital in Nedlands. Dr Alwan is also a part-time laboratory haematologist at Western Diagnostic Pathology. Professor Ross Baker MBBS BMedSc FRACP FACP FRCPAHaematologist / Clinical Trials Investigator Founding Director of PBI, Consultant Haematologist Professor Ross Baker has led large international clinical trials and clinical research in blood disorders including thrombosis, leukaemia, lymphoma, myeloma and haemophilia. He has authored over 100 papers in peer reviewed journals and is a renowned international speaker. He is a founding director and secretary of the Australasian Society for Thrombosis and Haemostasis and served as scientific advisor to the World Health Organisation on DVT in 2001. Dr Simon McRae MBBS FRACP FRCPAHaematologist / Investigator Dr Simon McRae completed haematology training in Tasmania, New South Wales, and Scotland; and undertook a 3-year clinical fellowship in venous thrombosis management at McMaster University, Ontario. Dr McRae has worked as a consultant haematologist throughout Australia including time as the Director of Clinical Haematology at both the Royal Adelaide and Launceston General Hospitals. Dr McRae has a particular interest in the management of venous thrombosis and bleeding disorders and has been involved in clinical trials as a principal investigator for over two decades. He has over 50 peer reviewed publications and book chapters and has been a contributing author to consensus international guidelines in his areas of interest. He has also previously served as an executive of the Australian Society of Thrombosis and Haemostasis (ASTH now THANZ) and was chair of the Australian Haemophilia Centre Directors Organisation (AHCDO) for over 6 years. Dr McRae joined the Western Haematology & Oncology Clinic in January 2022 as Consultant Haematologist and principal investigator for Perth Blood Institute.